4.0
23 Apr 2014
Former employee, more than 8 years
Recommend
CEO approval
Business outlook
Pros
Bright people, global exposure, technically competent. The broad based markets they're involved with give you a window into many industrial areas.
Cons
The new mgt would seem to be prepping the business for a sale. Selling off divisions and shifting operation. After Millipore was sold to German Merck, it can't be too long before Pall's sold too.